Alopex Gold Inc. Announces Name Change to AEX Gold Inc.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
28
Alopex Gold Inc. Announces Name Change to AEX Gold Inc.

TORONTO, June 06, 2018 (GLOBE NEWSWIRE) -- Alopex Gold Inc. (the " Corporation " or " Alopex ") (TSXV:AEX) is pleased to announce that it has filed Articles of Amendment to change its name to AEX Gold Inc. The Corporation's shareholders approved a special resolution to change the name of the Corporation at the Corporation's annual general and special meeting of shareholders held on May 24, 2018. The name change is effective June 6, 2018 and is subject to acceptance from the TSX Venture Exchange.

Effective at the start of trading on or about June 8, 2018, the Company will commence trading on the TSX Venture Exchange under the new name and the existing stock symbol "AEX".

No further action is required by existing shareholders with respect to the name change and certificates representing common shares of Alopex Gold Inc. will not need to be exchanged.

About Alopex

Alopex's principal business objectives are the identification, acquisition, exploration and development of gold properties in Greenland. The Corporation's principal asset is a 100% interest in the Nalunaq Project, an advanced exploration stage property with an exploitation licence including the previously operating Nalunaq gold mine. Alopex is incorporated under the Canada Business Corporations Act and wholly owns Nalunaq A/S, incorporated under the Greenland Public Companies Act.

CONTACT INFORMATION

George Fowlie Director of Corporate Development 1-416-587-9801 gfowlie@grfcapital.com

Forward-Looking Information

This press release includes certain "forward-looking statements". All statements other than statements of historical fact included in this press release, including without limitation statements regarding the future plans and objectives of the Corporation, are forward-looking statements that involve various risks and uncertainties. These forward-looking statements include, but are not limited to, statements with respect to pursuing successful production and exploration programs, and other information that is based on forecasts of future operational or financial results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates" or "intends" or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be "forward-looking statements". Forward-looking statements are subject to a variety of risks and uncertainties that could cause actual events or results to differ from those reflected in the forward- looking statements. There can be no assurance that forward-looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Corporation's expectations include, among others, risks related to the ability to raise additional capital proposed expenditure for exploration work and general and administrative expenses, international operations, the actual results of current exploration activities, conclusions of economic evaluations and changes in project parameters as plans continue to be refined as well as future prices of gold and other precious and non-precious metals. Although the Corporation has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Any forward-looking information included in this press release is based only on information currently available to the Corporation and speaks only as of the date on which it is made. Except as required by applicable securities laws, the Corporation assumes no obligation to update or revise any forward-looking information to reflect new circumstances or events.

No securities regulatory authority has either approved or disapproved of the contents of this press release. Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 31

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 31

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 25

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Breast Suite Transforming Cancer Detection and Care

Updated Category News Views 118

Introducing the AI-Driven DeepHealth Breast Suite DeepHealth has recently launched its Breast Suite, a revolutionary set of AI-powered applications that significantly boosts the effectiveness of breast cancer detection and patient care. This suite is part of a broader initiative to improve health informatics and operational efficiency, showcasing DeepHealth's commitment...

Continue Reading
AVATR Unveils Innovative Luxury Electric Vehicle in Munich

Updated Category News Views 193

AVATR Unveils Innovative Luxury Electric Vehicle in Munich At the recent "Brilliant New Horizon AVATR Brand Day" event, the President of AVATR Technology, Mr. Chen Zhuo, shared insights about the brand's identity. He explained that AVATR transcends the typical electric vehicle company image by embracing high-end sophistication, intelligence, and design. Emotional...

Continue Reading
Security Federal Corporation Expands Stock Repurchase Program

Updated Category News Views 128

Security Federal Corporation Unveils New Stock Repurchase Program Security Federal Corporation (the “Company”) (OTCBB: SFDL), which serves as the holding company for Security Federal Bank (the “Bank”), has recently announced an increase in the number of shares it is authorized to repurchase under its existing stock repurchase program. This updated initiative...

Continue Reading
Experience 'Hot Fellas' Bakery: Immersive NYC Event Awaits

Updated Category News Views 379

Unveiling the Hot Fellas Bakery Pop-Up Experience in NYC The beloved storyline of the Max Original series "And Just Like That…" springs to life with an exciting two-day immersive pop-up event. Fans will have the unique opportunity to step into Anthony Marentino's famous 'Hot Fellas' Bakery, inviting them to participate in a fun and delicious experience. Details of the...

Continue Reading
EyePoint Pharmaceuticals Pursues Major Stock Offering for Growth

Updated Category News Views 228

EyePoint Pharmaceuticals Pursues Major Stock Offering EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a leader in developing innovative therapies for patients suffering from serious retinal diseases, has taken a significant step toward advancing its initiatives by announcing a proposed underwritten public offering. The company is set to offer $150 million of its common...

Continue Reading